SCHEMBL17486245

SCHEMBL17486245

CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4ccc5c(c4)C(C)(C)C(C)(C)C5(C)C)nc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
ALDH1A1 P00352 1/20 0.35
TDO2 P48775 1/20 0.35
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
MAPT P10636 3/20 0.32
TP53 P04637 2/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
XDH P47989 1/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17485978 0.96 NPC1 (0.39) NPC1RAB9AALDH1A1TDO2HSD17B1
SCHEMBL17486302 0.94 TDO2 (0.37) NPC1RAB9AALDH1A1TDO2HSD17B1
SCHEMBL17486155 0.92 KDM4E (0.40) NPC1RAB9ATDO2HSD17B1HSD17B2
SCHEMBL17486090 0.86 HSD17B1 (0.33) HSD17B1HSD17B2
SCHEMBL17486301 0.86 HSD17B1 (0.33) HSD17B1HSD17B2
SCHEMBL19295133 0.85 HSD17B1 (0.35) HSD17B1HSD17B2RARBRARG
SCHEMBL17486227 0.85 HSD17B1 (0.41) NPC1RAB9AALDH1A1HSD17B1HSD17B2
SCHEMBL19295157 0.84 NPC1 (0.36) NPC1RAB9AALDH1A1TDO2MAPT
SCHEMBL17486242 0.84 GRM5 (0.35) NPC1HSD17B1HSD17B2
SCHEMBL17486244 0.84 HSD17B1 (0.40) NPC1RAB9AALDH1A1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3583111-B1 PROCESS FOR PREPARING ORTHO-METALLATED METAL COMPOUNDS MERCK PATENT GMBH (DE) 2020-12-23 EP disclosed
US-20200048289-A1 PROCESS FOR PREPARING ORTHO-METALLATED METAL COMPOUNDS MERCK PATENT GMBH (DE) 2020-02-13 US disclosed
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048289-A1 PROCESS FOR PREPARING ORTHO-METALLATED METAL COMPOUNDS NISCH, SOD1, MDM4 NPC1 4206/4885RAB9A 125/4885ALDH1A1 3052/4885
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 NPC1 3516/4885RAB9A 2201/4885ALDH1A1 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.